This decline may relate to earlier diagnosis via widespread abdominal imaging (e.g., computed tomography scans), which detects asymptomatic kidney tumors incidentally (Shehata et al., 2021) and clinical use of targeted therapies (e.g., vascular endothelial growth factor inhibitors) and immunotherapies (Ding et al., 2021; Pal et al., 2019). Here, VEGFA is linked to kidney neoplasm.